GREENFIELD, Ind., Sept. 19, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia™, a safe, highly ...
On Thursday, the FDA approved Elanco Animal Health Incorporated’s (NYSE:ELAN) Zenrelia, a once-daily oral JAK inhibitor for the control of pruritus (itching) associated with allergic dermatitis and ...
Buckaroo before Zenrelia (left); Buckaroo after Zenrelia treatment (middle and right) Hunter, Trooper, Scrappy and Buckaroo find zen by using Zenrelia Newly published study in a leading peer-reviewed, ...
Sept 19 (Reuters) - The U.S. Food and Drug Administration has approved Elanco Animal Health's (ELAN.N), opens new tab skin disease treatment for dogs, the health regulator's website showed on Thursday ...
The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market ...
Federal regulators have approved a new dermatology treatment for itchy dogs made by Elanco Animal Health Inc. that the company has touted as a potential blockbuster. Greenfield-based Elanco said ...
A Stifel analyst maintained a Buy rating and a $20.00 price target for Elanco Animal Health (NYSE:ELAN), following a recent public call which provided new insights on Zenrelia, the company's atopic ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
In fact, a newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, described the findings of a randomized, clinical trial which compared Zenrelia to the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
GREENFIELD, Ind., July 24, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Zenrelia™ (ilunocitinib) has received approval by the European Commission. Elanco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results